From Patient Data to Market Access — in Brazil
The evidence CONITEC demands. The insights your global team needs. iHealth is the only Brazilian RWE partner with integrated EHR, lab, and pharmacy data across 5 regions — powering regulatory submissions, market access strategy, and scientific evidence for pharma.
~5M Patient Lives | 30 Hospitals | 5 Brazilian Regions
What We Offer
Our unified platform connects evidence generation, market access strategy, and commercial intelligence on a single data backbone.
Real-World Evidence (RWE)
Generate regulatory-grade evidence from LATAM real-world data. External control arms, comparative effectiveness, burden of disease studies.
ECA Builder Comparative Cohorts Living RegistriesHEOR & Health Economics
Cost-effectiveness analyses, budget impact models, and value frameworks tailored for Brazilian and LATAM HTA bodies.
CONITEC Dossiers Value Narratives Economic ModelsMarket Access Strategy
Navigate Brazil's complex payer landscape. Strategic consulting for public and private reimbursement.
HTA Evidence Pack Access Pathways Payer StrategyCommercial Intelligence
RWE-driven market insights, patient journey mapping, and launch analytics for data-driven commercial decisions.
JourneyMap LaunchPulse Treatment LandscapeTherapeutic Focus
Oncology
Deep expertise in solid tumors and hematological malignancies. Comprehensive access to Brazilian cancer registries and treatment data.
- Solid tumors (lung, breast, colorectal, prostate, melanoma)
- Hematological cancers (leukemia, lymphoma, myeloma)
- Precision oncology and biomarker-driven therapies
- Supportive care and palliative treatment patterns
Rare Diseases
Navigate the unique challenges of orphan drug development with our comprehensive rare disease expertise and patient identification capabilities.
- Genetic and metabolic disorders
- Rare pediatric conditions
- Ultra-rare disease registries
- Natural history studies
Data PowerHouse Architecture
Our three-layer platform delivers integrated insights across the product lifecycle:
Layer 1: Data PowerHouse (Foundation)
Unified real-world data backbone connecting disparate sources. Patient360 LATAM, federated data collaboration, LGPD-first de-identification, Portuguese-first clinical NLP.
Layer 2: Evidence & Science Engine
RWE generation, HEOR studies, pragmatic research. ECA Builder, Comparative Cohorts, Trial Feasibility Index, Living Registries, Burden & Epidemiology Kit.
Layer 3: Value & Access Studio
Market access strategy, value narratives, dossier inputs. HTA Evidence Pack, Value Narrative Studio, Access Pathways Navigator.
Key Capabilities
- External Control Arms: Build synthetic control groups from real-world data to support regulatory submissions
- Trial Feasibility: Data-driven site selection and enrollment projections for LATAM clinical trials
- HTA Readiness: Prepare comprehensive value dossiers for CONITEC and regional HTA bodies
- Launch Monitoring: Track real-world product performance and optimize commercial strategy
- Burden of Disease: Characterize disease burden and unmet need in LATAM populations
- Treatment Patterns: Map real-world treatment sequences and outcomes
Who We Serve
HEOR Teams
Generate evidence for value dossiers, support HTA submissions, and demonstrate real-world effectiveness.
Market Access
Navigate payer negotiations, develop access strategies, and secure reimbursement in complex markets.
Medical Affairs
Support scientific publications, real-world evidence programs, and KOL engagement with robust data.
Clinical Development
Inform trial design, identify patients, build external control arms, and accelerate development timelines.
Commercial Strategy
Understand market dynamics, patient journeys, and competitive landscape for strategic planning.
Why iHealth?
- Deep LATAM Expertise: Unmatched access to Brazilian and LATAM real-world data
- Oncology & Rare Disease Focus: Purpose-built for complex specialty therapeutics
- Integrated Platform: Evidence, access, and commercial on one data backbone
- Regulatory Grade: Meet FDA, EMA, ANVISA, and global regulatory standards
- Speed to Insight: Pre-integrated data enables faster study turnaround
- Strategic Partnership: Not just data—strategic guidance and scientific expertise
Frequently Asked Questions
How is iHealth different from a traditional CRO?
Traditional CROs focus on operational trial execution. iHealth focuses on strategic evidence generation, value demonstration, and commercial intelligence using real-world data, specifically tailored for complex specialty care.
Do you have data coverage in LATAM?
Yes. A key differentiator is our deep, granular data access and regulatory expertise in Brazil and broader LATAM, providing evidence that global teams often lack.
Can you support Global HQ teams?
Absolutely. We often work as the bridge, translating local market reality into evidence that supports Global Value Dossiers and HQ strategic planning.
What therapeutic areas do you specialize in?
Our deep expertise is in Oncology (solid and heme) and Rare Diseases. We built our Data PowerHouse specifically to handle the complexity of these data types.
How quickly can you generate a study?
Because our Data PowerHouse is pre-integrated, we can often move from protocol to preliminary insights significantly faster than ad-hoc chart review studies.
Do you offer software or consulting?
Both. We are a Tech-Enabled Services partner. You get the speed of our platform combined with the strategic guidance of our expert team.
Ready to Transform Your Evidence Strategy?
Let's discuss how iHealth can accelerate your path to market access in Brazil and LATAM.
Schedule a Consultation Email Us
Trusted by Leading Pharma Companies & Hospital Networks
Part of Brazil's largest clinical data alliance
Pharma & Industry Partners
Sanofi, Novartis, Roche, Pfizer, AstraZeneca, Bayer, Takeda, Abbvie, J&J, MSD
Hospital Network (ALIANSA)
CMB, Santa Casa SP, Santa Casa BH, Santa Casa POA, Santa Casa Recife, Hospital São José, Hospital Mãe de Deus, FHEMIG, Hospital Conceição, Hospital Santa Isabel
Case Study — Immunology
Real-World Treatment Mapping for a Top-10 Global Pharma
Using our clinical NLP engine, we mapped the complete treatment journey for patients with moderate-to-severe atopic dermatitis across multiple hospital sites — identifying prescribing patterns, line-of-therapy sequencing, biomarker correlations, and real-world outcomes that traditional audit data cannot capture.
Details anonymized for confidentiality.